NasdaqGS - Nasdaq Real Time Price USD
Ovid Therapeutics Inc. (OVID)
0.2722
-0.0287
(-9.54%)
At close: May 30 at 4:00:00 PM EDT
0.2961
+0.02
+(8.78%)
After hours: May 30 at 7:45:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.15 | -0.14 | -0.58 | -0.63 |
| Low Estimate | -0.16 | -0.16 | -0.63 | -0.75 |
| High Estimate | -0.14 | -0.12 | -0.52 | -0.4 |
| Year Ago EPS | 0.12 | -0.2 | -0.37 | -0.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 5 |
| Avg. Estimate | 93.17k | 78k | 329.71k | 329.6k |
| Low Estimate | -- | -- | 100k | -- |
| High Estimate | 169k | 173k | 570k | 700k |
| Year Ago Sales | 169k | 173k | 566k | 329.71k |
| Sales Growth (year/est) | -44.87% | -54.91% | -41.75% | -0.03% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.24 | -0.23 | -0.17 | -0.13 |
| EPS Actual | 0.12 | -0.2 | -0.13 | -0.14 |
| Difference | 0.36 | 0.03 | 0.04 | -0.01 |
| Surprise % | 150.12% | 11.89% | 22.19% | -7.69% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.14 | -0.58 | -0.63 |
| 7 Days Ago | -0.16 | -0.16 | -0.61 | -0.7 |
| 30 Days Ago | -0.13 | -0.15 | -0.56 | -0.65 |
| 60 Days Ago | -0.13 | -0.15 | -0.6 | -0.62 |
| 90 Days Ago | -0.14 | -0.15 | -0.65 | -0.63 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 2 |
| Down Last 30 Days | 1 | 1 | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OVID | -225.00% | 28.34% | -55.86% | -9.83% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/27/2025 |
| Maintains | BTIG: Buy to Buy | 3/24/2025 |
| Maintains | Wedbush: Outperform to Outperform | 3/12/2025 |
| Upgrade | Oppenheimer: Perform to Outperform | 1/29/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/30/2024 |
Related Tickers
CNTX Context Therapeutics Inc.
0.5771
-6.50%
IPSC Century Therapeutics, Inc.
0.5304
-4.78%
RLYB Rallybio Corporation
0.3090
-3.13%
GBIO Generation Bio Co.
0.3782
-2.58%
ERNA Ernexa Therapeutics Inc.
0.2180
-4.80%
TNFA TNF Pharmaceuticals, Inc.
0.1604
-3.14%
ELEV Elevation Oncology, Inc.
0.3001
-1.96%
CGTX Cognition Therapeutics, Inc.
0.2390
-3.86%
SNSE Sensei Biotherapeutics, Inc.
0.3015
+0.50%
RENB Renovaro Inc.
0.3097
-1.68%